DEF: Solsence, Inc. Seeks Shareholder Approval for Director Elections and New Equity Plan at 2025 Annual Meeting

Sentiment:

Definitive Proxy Statement


Solsence, Inc. has filed its definitive proxy statement for the 2025 Annual Meeting of Stockholders, outlining proposals for director elections, approval of a new equity compensation plan, and ratification of its independent auditors.

Delay expectedMaturity dates for the A&R Revolver Facility, Inventory Facility, and Term Loan Agreement with related parties (Strandler, LLC and Beachcorp, LLC) were extended multiple times: from November 13, 2023, to March 31, 2025; then on March 1, 2024, to October 1, 2025; and most recently on May 27, 2025, to April 30, 2027.
Capital raiseThe company has engaged in a series of debt and equity transactions with Bradford T. Whitmore through his affiliates, Strandler, LLC and Beachcorp, LLC, since January 1, 2022, including a promissory note for $2,000,000 on November 13, 2023.The proposed 2025 Equity Compensation Plan seeks to increase the aggregate number of shares available for grants to 3,000,000, replacing the 2019 plan which had fewer than 7,000 shares remaining, indicating a need for more equity for compensation.
Worse than expectedTotal Shareholder Return based on a $100 investment on December 31, 2021, was $55 in 2024, $14 in 2023, and $26 in 2022, indicating a significant decline in shareholder value over the period.Performance milestones were not met in 2023, resulting in no bonuses paid to executive officers for that year.

Summary

  • The 2025 Annual Meeting of Stockholders for Solsence, Inc. will be held on Thursday, August 28, 2025, at 8:00 a.m. Central time, at the company's corporate headquarters.
  • Shareholders will vote on three key proposals: the election of two Class I directors (Ms. R. Janet Whitmore and Ms. Laura M. Beres) for three-year terms expiring in 2028, the approval of the 2025 Equity Compensation Plan, and the ratification of RSM US LLP as the independent auditors for the year ending December 31, 2025.
  • The Board of Directors recommends a 'FOR' vote for all three proposals.
  • As of the record date, July 21, 2025, Solsence, Inc. had 70,481,945 shares of common stock outstanding.
  • The proposed 2025 Equity Compensation Plan is designed to replace the existing 2019 plan, increasing the aggregate number of shares available for grants to 3,000,000, from fewer than 7,000 shares remaining in the prior plan.
  • Executive compensation for Jess Jankowski (CEO) in 2024 totaled $565,348, including a $141,569 bonus, while Kevin Cureton (COO) received $481,309, with a $111,016 bonus, reflecting partial achievement of performance milestones in 2024.
  • In contrast, no bonuses were paid in 2023 as performance milestones were not met.
  • The company reported a net income of $4,235,000 in 2024, a significant improvement from net losses of $(4,390,000) in 2023 and $(2,623,000) in 2022.
  • Total Shareholder Return, based on a $100 investment on December 31, 2021, was $55 in 2024, $14 in 2023, and $26 in 2022, indicating a substantial decline in shareholder value over the period.
  • The company is considered a 'controlled company' under Nasdaq rules due to Bradford T. Whitmore's beneficial ownership of 70.7% of outstanding shares as of June 30, 2025.

Sentiment

Score: 4

Explanation: While the company reported a net profit in 2024 and partially achieved performance milestones, the significant decline in Total Shareholder Return since 2021 and the repeated extensions of related-party debt maturity dates raise concerns about long-term value creation and financial stability. The late Section 16(a) filings also indicate administrative issues.

Positives

  • The company achieved a net income of $4,235,000 in 2024, reversing losses from the prior two years.
  • Executive officers received bonuses in 2024, indicating that performance milestones were partially achieved.
  • The proposed 2025 Equity Compensation Plan aims to strengthen the company's ability to attract and retain key employees and directors, which is vital for long-term growth and technology leadership.
  • The Board of Directors recommends approval of all proposals, including the election of experienced directors and the new equity plan.

Negatives

  • Performance milestones were not met in 2023, resulting in no bonuses paid to executive officers for that year.
  • Total Shareholder Return has significantly declined, with a $100 investment on December 31, 2021, valued at only $55 by 2024, $14 by 2023, and $26 by 2022.
  • Several Section 16(a) reports for directors and executive officers were filed late in 2024 and early 2025 due to administrative errors and oversight.

Risks

  • The company's status as a 'controlled company' under Nasdaq rules exempts it from requirements for a majority of independent directors, an independent compensation committee, or independent director oversight of director nominations, which could impact corporate governance standards.
  • The company relies on related-party debt, with multiple extensions of maturity dates for loan agreements with affiliates of a principal stockholder, Bradford T. Whitmore, potentially indicating ongoing financial reliance or challenges in securing external financing.
  • The significant decline in Total Shareholder Return over recent years suggests potential risks to shareholder value and investor confidence.

Future Outlook

The company's proposed 2025 Equity Compensation Plan is intended to strengthen its capacity to attract and retain key employees and directors, which management believes is vital for maintaining its technology leadership position in advanced materials and fully formulated skin health products and for achieving long-term growth and financial success.

Management Comments

  • "On behalf of the Board of Directors, I invite you to attend the 2025 Annual Meeting of Stockholders of Solsence, Inc."
  • "Whether or not you choose to attend the Annual Meeting, it is important that your shares be represented."
  • "The Board of Directors believes this to be the most appropriate structure for the Company at this time." (referring to separate CEO and Board Chair roles)
  • "The Board believes that the equity compensation available under the 2025 Plan is vital to our ability to secure and build the Company’s talented human resources and thereby remain competitive and a technology leader in our industry."

Industry Context

The company operates in the advanced materials and fully formulated skin health products industry, where competition for talented employees is a recognized factor. The proposed 2025 Equity Compensation Plan is positioned as a strategic tool to maintain the company's technology leadership and competitiveness within this industry.

Comparison to Industry Standards

  • NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board StructureThe Board of Directors consists of four directors, classified into three classes with three-year terms. Two Class I directors are up for re-election.NAMaintains existing staggered board structure.
Director IndependenceMs. Beres and Mr. Miller are determined to be independent directors. The company qualifies as a 'controlled company' due to Bradford T. Whitmore's 70.7% ownership, exempting it from certain Nasdaq independence requirements.NAThe 'controlled company' status allows the company to operate without a majority of independent directors or fully independent compensation and nominating committees, which could reduce independent oversight.
Committee CompositionMs. Whitmore, who is not independent due to related party ownership, chairs both the Compensation Committee and the Nominating and Corporate Governance Committee, relying on a Nasdaq limited exception for controlled companies.NAThis structure may raise questions about the independence of executive compensation and director nomination processes, despite the Board's belief that it is in the company's best interest.
Risk Oversight PhilosophyThe Board focuses on evaluating risk at the entity and strategic levels, with management responsible for day-to-day risk factors. The roles of CEO (Jess Jankowski) and Board Chair (R. Janet Whitmore) are segregated.NAThis segregation of roles is generally considered a positive governance practice, providing a check on executive power.
Equity Compensation PlanProposal to approve the 2025 Equity Compensation Plan, which will replace the 2019 plan and increase the shares available for grants to 3,000,000.Upon shareholder approvalIf approved, this plan will provide more equity incentives for employees and directors, potentially aiding talent retention and alignment with shareholder interests, but also carries potential for dilution.
Hedging and Insider Trading PoliciesThe company has policies prohibiting directors, officers, and employees from trading during blackout periods, short-term trading, margin purchases, short sales, options, and hedging transactions. Insider trading policies are part of the Code of Business Conduct and Ethics.NAThese policies are standard good governance practices designed to prevent market manipulation and ensure fair trading.
Section 16(a) ComplianceSeveral Section 16(a) reports for directors and executive officers were filed late in 2024 and early 2025 due to administrative errors and oversight.NAIndicates administrative weaknesses in compliance reporting, which could be a red flag for regulatory scrutiny or internal control deficiencies.

Related Party Transactions

  • The company has engaged in a series of debt and equity transactions with Bradford T. Whitmore, a principal stockholder, through his affiliates, Strandler, LLC and Beachcorp, LLC, since January 1, 2022.
  • A promissory note in the amount of $2,000,000 was issued on November 13, 2023, to a related party.
  • Existing A&R Revolver Facility, Inventory Facility, and Term Loan Agreement maturity dates were extended multiple times: from November 13, 2023, to March 31, 2025; then on March 1, 2024, to October 1, 2025; and most recently on May 27, 2025, to April 30, 2027.

Stakeholder Impact

  • Shareholders are directly impacted by the proposals, particularly the election of directors and the approval of the 2025 Equity Compensation Plan, which could affect future share dilution and governance.
  • Employees and directors stand to benefit from the proposed 2025 Equity Compensation Plan, which aims to provide incentives and aid in talent retention.
  • Creditors, particularly related parties, are impacted by the extensions of debt maturity dates, which could signal ongoing financial reliance on these parties.

Next Steps

  • Stockholders are urged to vote their shares via telephone, over the Internet, or by mail prior to August 28, 2025.
  • The Annual Meeting of Stockholders will be held on August 28, 2025, where proposals for director elections, the 2025 Equity Compensation Plan, and auditor ratification will be voted upon.
  • Management will be available to answer questions immediately after the Annual Meeting.

Key Dates

DateDescription
2001-11-01RSM US LLP engaged as auditors for the Company.
2003-11-01R. Janet Whitmore joined the Board of Directors.
2005-01-01Company adopted and stockholders approved the 2005 Non-Employee Director Restricted Stock Plan and the Non-Employee Director Deferred Compensation Plan.
2009-02-01Jess A. Jankowski joined the Board of Directors.
2009-08-12Employment agreement with Jess Jankowski became effective.
2012-11-01Kevin Cureton joined the Company as Vice President of Sales, Marketing and Business Development.
2012-11-28Employment agreement with Kevin Cureton became effective.
2017-11-01Jess Jankowski served as Principal Financial Officer and Principal Accounting Officer until March 2018.
2018-01-01Kevin Cureton named Chief Commercial Officer.
2019-04-01Jess Jankowski resumed serving as Principal Financial Officer and Principal Accounting Officer.
2019-11-01The 2010 Equity Plan was consolidated into the 2019 Equity Compensation Plan.
2019-12-01Kevin Cureton became Chief Operating Officer.
2020-10-01Laura M. Beres joined the Board of Directors.
2021-12-31Baseline date for Total Shareholder Return calculation ($100 investment).
2022-01-01Beginning of period for series of debt and equity transactions with Bradford T. Whitmore's affiliates.
2023-07-01Mark E. Miller joined the Board of Directors.
2023-11-13Promissory note for $2,000,000 issued; existing A&R Revolver Facility, Inventory Facility, and Term Loan Agreement maturity dates extended to March 31, 2025.
2024-03-01Maturity dates for A&R Revolver Facility, Inventory Facility, and Term Loan Agreement further extended to October 1, 2025.
2024-12-31End of fiscal year for which financial statements were audited; date for outstanding equity awards information; date of annual stock option grants to Outside Directors and NEOs.
2025-01-13Late filing date for annual stock option grants made on December 31, 2024.
2025-05-27Maturity dates for A&R Revolver Facility, Inventory Facility, and Term Loan Agreement further extended to April 30, 2027.
2025-06-30Date for beneficial ownership information.
2025-07-21Record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting.
2025-07-30Date of the Dear Stockholder letter and Notice of Annual Meeting.
2025-08-14Approximate mailing date of the 2025 Proxy Statement and proxy card.
2025-08-28Date of the 2025 Annual Meeting of Stockholders; deadline for proxy votes.
2026-04-01Deadline for stockholder proposals to be considered for inclusion in the 2026 Annual Meeting proxy statement.
2026-06-30Deadline for stockholder proposals (not under Rule 14a-8) for the 2026 Annual Meeting.
2027-01-01Jess A. Jankowski and Mark E. Miller's director terms expire.
2027-04-30New maturity date for A&R Revolver Facility, Inventory Facility, and Term Loan Agreement.
2028-01-01R. Janet Whitmore and Laura M. Beres's director terms expire.

Recommendation

hold

While Solsence, Inc. achieved a net profit in 2024 and is proposing an equity compensation plan to attract and retain talent, the substantial decline in Total Shareholder Return since 2021 and the repeated extensions of related-party debt maturity dates indicate underlying financial and operational challenges. The 'controlled company' status and late insider filings also present governance concerns. Given these mixed signals, a 'hold' recommendation is appropriate, suggesting investors monitor future financial performance, debt management, and governance improvements before making further investment decisions.

Keywords

Solsence, SEC filing, proxy statement, annual meeting, corporate governance, equity compensation plan, director election, independent auditors, executive compensation, related party transactions, shareholder return, financial performance, controlled company

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.